Akebia Therapeutics (AKBA)
(Delayed Data from NSDQ)
$1.33 USD
-0.04 (-2.92%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.33 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Akebia Therapeutics (AKBA) reported earnings of $0.00 per share, beating the Zacks Consensus Estimate of $-0.05 per share. This reflects a positive earnings surprise of 100.00%. Look out for AKBA's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 35.71%.
Earnings History
Price & Consensus
Zacks News for AKBA
Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q4
AKBA: What are Zacks experts saying now?
Zacks Private Portfolio Services